Welcome to the ePoster Viewing Panel of AICOG 2025

Introduction: Implanon-Nxt is the progestogen-only, single rod subdermal implant which is recently introduced by Government of India (GOI) in the expanded basket of contraceptives. To build client?s and service provider?s trust in this new contraceptive, it is imperative to generate evidence and disseminate the experience. Aims and Objectives: To evaluate menstrual pattern, side effects, continuation rate and premature removals among subdermal implants users. Material & Methods: In this ambispective study, clients who have completed 6 weeks post-insertion were enrolled. Type of insertion whether interval, post-abortal or postpartum was noted. Clients were followed up at 6 weeks and and 3 months after insertion in accordance with the GOI guidelines with additional visits if required. In the follow-ups, bleeding pattern, any side effect, premature removals with the reasons were noted. Results: A total of 460 couples seeking contraception and opting for implants have completed their 6-weeks follow up post-insertion. Of these, 145 (31.52%) were interval insertions, 78 (16.95%) were post-abortion and 237 (51.53%) were postpartum insertions. Among the users, 37(8%) women complained of heavy bleeding; and 82(17%) had irregular or prolonged bleeding or continuous spotting. Other side effects included local site pain or itching, headache, mood changes and breast tenderness. Total 17/460 (3.7%) clients underwent premature implant removal, the most common reason was heavy bleeding or continuous or irregular spotting seen in 10/17 (58.9%) women. Hence the continuation rates for implant users in our centre is 96.3% in the initial two years of implant use as contraceptive. Conclusions: Implanon-Nxt, etonorgestrel containing subdermal implant has expanded the choices for long-acting reversible contraceptives (LARC) as postpartum, postabortal or interval methods. In the initial two years of implant use as a new contraceptive in India, there was high continuation rate of 96.3%. The most common reason for premature removal was heavy bleeding or continuous spotting.